PFFOF yields 32786.89% · PFE yields 6.13%● Live data
📍 PFFOF pulled ahead of the other in Year 1
Combined, PFFOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PFFOF + PFE for your $10,000?
Portofino Resources Inc. acquires, explores for, and develops mineral properties in the Americas. The company holds an option to acquire 100% interests in the Sapawe West property that comprises 3 claims totaling 1,147 hectares located in the Schwenger and McCaul Townships, Ontario; the Gold Creek property comprising 15 mining claims containing 197 contiguous cell units covering an area of approximately 4,036 hectares located primarily in the Duckworth Township, Ontario; and the Melema West gold property covering an area of 869 hectares located to the northeast of the town of Atikokan, Ontario. It also holds an option to acquire 100% interest in the South of Otter project covering an area of 5,363 hectares located to the southeast of the town of Red Lake, Ontario. In addition, the company has option assignment agreement to acquire a 100% interest in the Bruce Lake property that comprises 5 mineral claims totaling 1,428 hectares located in the Red lake, Ontario; the Allison Lake North property comprises 4 claims totaling 1,618 hectares located to the east of the Red Lake in northwestern Ontario; the Allison Lake North Birkett and Costello Lake property located in northwestern Ontario; holds a 100% interest in the Greenheart Lake property comprises 3 claims totaling approximately 1,200 hectares; and McNamara lithium property comprises 3 claims totaling approximately 1,120 hectares located in northwestern, Ontario. The company was formerly known as Crude Investments Corp. and changed its name to Portofino Resources Inc. in March 2012. Portofino Resources Inc. was incorporated in 2011 and is headquartered in Vancouver, Canada.
Full PFFOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.